Prevention of programmed cell death in Caenorhabditis elegans by human bcl-2
about
SAG, a novel zinc RING finger protein that protects cells from apoptosis induced by redox agentsProapoptotic BAX and BAK control multiple initiator caspasesThe conserved N-terminal BH4 domain of Bcl-2 homologues is essential for inhibition of apoptosis and interaction with CED-4A common binding site mediates heterodimerization and homodimerization of Bcl-2 family membersICE-LAP3, a novel mammalian homologue of the Caenorhabditis elegans cell death protein Ced-3 is activated during Fas- and tumor necrosis factor-induced apoptosisA conserved domain in Bak, distinct from BH1 and BH2, mediates cell death and protein binding functionsCloning and expression of apoptosis inhibitory protein homologs that function to inhibit apoptosis and/or bind tumor necrosis factor receptor-associated factorsMolecular cloning of a human cDNA encoding a novel protein, DAD1, whose defect causes apoptotic cell death in hamster BHK21 cellsDAD1, the defender against apoptotic cell death, is a subunit of the mammalian oligosaccharyltransferaseAn apoptosis-inhibiting gene from a nuclear polyhedrosis virus encoding a polypeptide with Cys/His sequence motifsEzrin, a plasma membrane-microfilament linker, signals cell survival through the phosphatidylinositol 3-kinase/Akt pathwayRegulated necrotic cell death: the passive aggressive side of Bax and BakGenetic ablation of Bcl-x attenuates invasiveness without affecting apoptosis or tumor growth in a mouse model of pancreatic neuroendocrine cancerThe C. elegans model in toxicity testingBH3-only proteins: a 20-year stock-takeApoptosis timelineApoptosis in the pathogenesis and treatment of diseaseBcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosisTargeted disruption of Bcl-2 alpha beta in mice: occurrence of gray hair, polycystic kidney disease, and lymphocytopeniaBcl-2 protein expression during murine developmentTwo CD95 (APO-1/Fas) signaling pathwaysOvarian toxicity of 4-vinylcyclohexene diepoxide: a mechanistic model.Regulation of caspase activation in apoptosis: implications in pathogenesis and treatment of disease.Expression of human Bcl-xL (Ser49) and (Ser62) mutants in Caenorhabditis elegans causes germline defects and aneuploidy.Commitment and effector phases of the physiological cell death pathway elucidated with respect to Bcl-2 caspase, and cyclin-dependent kinase activities.The molecular mechanism of programmed cell death in C. elegans.Role of the Fas pathway in Pseudomonas aeruginosa keratitis.Tissue-specific Bcl-2 protein partners in apoptosis: An ovarian paradigm.Crk is required for apoptosis in Xenopus egg extracts.Cancer models in Caenorhabditis elegans.Sequence analysis of eukaryotic developmental proteins: ancient and novel domains.Apoptosis: mechanisms and clinical implications.Trophic factors and stem cells for promoting recovery in stroke.The highly conserved defender against the death 1 (DAD1) gene maps to human chromosome 14q11-q12 and mouse chromosome 14 and has plant and nematode homologs.Regulation of cell survival and death during Flavivirus infections.SPK-1, an SR protein kinase, inhibits programmed cell death in Caenorhabditis elegans.The midblastula transition in Xenopus embryos activates multiple pathways to prevent apoptosis in response to DNA damage.Role of Bcl-2 family of proteins in malignancy.The Bcl-2 family: roles in cell survival and oncogenesis.A sensitive near-infrared fluorescent probe for caspase-mediated apoptosis: Synthesis and application in cell imaging.
P2860
Q22009063-6AD105F4-8428-4AF5-B54E-12DB5E2554C2Q24298402-AB291AB2-9D26-4284-AC03-7E18C25207E6Q24309225-F2D1A548-6AF0-4997-82DF-2F111C1DEC2DQ24314405-4E6C59E3-7096-4FB7-8F91-C6D75AB2A625Q24318803-E1E3E076-83B2-47A6-B0BB-AB4382EF14C4Q24597482-C02FE0BB-8F60-4F18-9F1F-80377B640F5DQ24600405-4886CF23-1EF8-4F9C-8307-DA24131E13ACQ24629674-D7FFFDAE-9FB8-4172-861D-285D3AE0D341Q24643677-02D0F7C4-C2F0-4722-87B5-84699FFA96CEQ24646704-1A910DDE-EED0-4D58-B618-0F457601D21BQ24648522-9D6E14BD-BA8F-41EC-BB54-857320B04773Q27021740-F55AE004-CECD-49E7-B581-6F18EEBBB43BQ27355520-061E6AAF-8B29-4B1E-B179-230101C60B53Q28071970-03439131-441A-4A68-BF94-53836BD56624Q28085220-B9B200B8-3DFE-476F-9AB0-762C2CB681B9Q28215321-A787E12F-D662-4C6C-9BA9-A394D969372AQ28235731-DB1F3841-3F67-462F-9580-5BE4743AE0B0Q28588677-DB51B4B4-8E64-4053-BDA5-AAB6DC9D9F2BQ28591736-ABA15494-9213-4342-AF76-2BCDB6790355Q28593853-12553E9A-6601-4665-A925-F02CA0D1D029Q29619631-E181CE56-AD70-494A-BACC-3E4F68C252BAQ32052625-BA9D39E7-1530-45EA-957E-EA343D35372DQ33606109-7D4280A3-C26D-4281-8751-D7BF16BFEB34Q33648335-38BCD6F1-CD29-458E-A65E-8D6D7C2D926AQ33786573-44F86020-93B7-4F3D-8C09-C327A392023CQ33834236-53139871-00F8-4E6B-A67D-52B4BE75786FQ33845475-915B7381-D910-4C30-8B5A-681BC36B260EQ33881268-EBC2B923-7761-4DFC-B296-CF63506D9958Q33885976-C6D29AE4-7C24-42A6-B7E6-E580DC69A241Q33903791-74EF1B27-59E2-4332-8DB2-F9E0A84A9937Q33968605-50D95D01-5E61-45A1-8087-3F48D3554E5FQ34078534-617DA129-EF80-4885-A4B4-6AD18A9BF7B4Q34240109-6A89ECC5-4EFD-44FF-9E37-1A63AD73361EQ34309796-E2EBF2C9-8B8A-43FF-AF67-A4C7308550ABQ34424352-1D90273B-7197-4646-8482-48FFA86140EFQ34550044-E0367559-EE77-4B47-890E-B3D3E644C62CQ34638113-DA6738B0-F0BC-4E1C-BE5C-7FC8A2E3B3E0Q34733047-72C8533B-F7DE-4B66-9626-F083D4D0E5D3Q35591695-1E944071-35B2-44FB-B411-5525B2FC3A25Q35691669-11151012-B719-4B41-A4D3-DA62B516B3A3
P2860
Prevention of programmed cell death in Caenorhabditis elegans by human bcl-2
description
1992 nî lūn-bûn
@nan
1992 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Prevention of programmed cell death in Caenorhabditis elegans by human bcl-2
@ast
Prevention of programmed cell death in Caenorhabditis elegans by human bcl-2
@en
Prevention of programmed cell death in Caenorhabditis elegans by human bcl-2
@nl
type
label
Prevention of programmed cell death in Caenorhabditis elegans by human bcl-2
@ast
Prevention of programmed cell death in Caenorhabditis elegans by human bcl-2
@en
Prevention of programmed cell death in Caenorhabditis elegans by human bcl-2
@nl
prefLabel
Prevention of programmed cell death in Caenorhabditis elegans by human bcl-2
@ast
Prevention of programmed cell death in Caenorhabditis elegans by human bcl-2
@en
Prevention of programmed cell death in Caenorhabditis elegans by human bcl-2
@nl
P2093
P3181
P356
P1433
P1476
Prevention of programmed cell death in Caenorhabditis elegans by human bcl-2
@en
P2093
P304
P3181
P356
10.1126/SCIENCE.1470921
P407
P577
1992-12-18T00:00:00Z